IPF Partners

Poxel S.A. is a biopharmaceutical company based in Lyon, France, focused on developing innovative treatments for metabolic diseases, primarily type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009 as a spin-off from Merck Serono, Poxel is advancing its lead product, Imeglimin, through Phase III clinical trials; this oral anti-diabetic candidate targets organ functions affected by diabetes, such as the pancreas, liver, and muscles. The company is also developing PXL770, currently in Phase IIa trials, which activates the adenosine monophosphate-activated protein kinase (AMPK) to manage energy metabolism, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I trials for NASH. Additionally, Poxel has a licensing agreement with Enyo Pharma for the development of PXL007, an FXR agonist in Phase I studies for hepatitis B and NASH. The company’s pipeline reflects its commitment to addressing critical targets in cellular energy regulation, which are vital for treating metabolic disorders.

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.

Caresyntax Inc. develops a technology platform specializing in surgical analytics to enhance safety and efficiency in hospitals and ambulatory surgical centers. The company offers solutions designed to identify and manage risks, automate workflows, and reduce variability in surgical procedures. Its flagship products include qvident, a performance management software that enables surgical teams to create and share surgical content, and PRIME365, an integration platform that consolidates key surgical data from various sources such as video, audio, patient vitals, and procedural timestamps. Caresyntax's offerings support a range of surgical procedures, from minimally invasive to robotic surgeries, and can be deployed as HIPAA-compliant software through on-premise, cloud-based, or hybrid installations. Established in 1991, Caresyntax is headquartered in Boston, Massachusetts.

Lumeon Ltd. is a digital health company specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and headquartered in London, the company offers a cloud-based platform known as the Care Pathway Manager, which provides a comprehensive, real-time view of the patient journey from referral to outcome. Lumeon's services encompass business analysis, project management, data migration, training, and ongoing support. By focusing on the entire care pathway, Lumeon aids healthcare providers in optimizing clinical and administrative workflows, automating tasks, and achieving measurable healthcare outcomes. The company serves a diverse range of clients, including some of Europe's leading healthcare organizations. Lumeon was previously known as Qinec Ltd. before rebranding in July 2016.

Lumeon Ltd. is a digital health company specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and headquartered in London, the company offers a cloud-based platform known as the Care Pathway Manager, which provides a comprehensive, real-time view of the patient journey from referral to outcome. Lumeon's services encompass business analysis, project management, data migration, training, and ongoing support. By focusing on the entire care pathway, Lumeon aids healthcare providers in optimizing clinical and administrative workflows, automating tasks, and achieving measurable healthcare outcomes. The company serves a diverse range of clients, including some of Europe's leading healthcare organizations. Lumeon was previously known as Qinec Ltd. before rebranding in July 2016.

SpineGuard SA is a medical device company headquartered in Vincennes, France, focused on enhancing the safety of spinal surgeries worldwide. Established in 2009, the company designs, develops, and markets innovative products aimed at improving pedicle screw placement during surgical procedures. Its key offerings include the PediGuard Straight probe, PediGuard Curved probe, PediGuard Cannulated probe, and the PediGuard Threaded Device, all designed to facilitate accurate screw placement while minimizing radiation exposure. Additionally, SpineGuard provides the DSG Connect app for real-time signal visualization during pedicle drilling, as well as the DSG smart screw for single-step screw placement. The company's primary goal is to establish PediGuard as the standard of care for safer spinal procedures, ultimately benefiting patients, surgeons, and healthcare providers.

Genesis Automation USA, Inc. specializes in supplies management, analytics, and traceability solutions tailored for the healthcare sector. The company focuses on enhancing clinical and patient outcome data management, facilitating patient-level cost tracking, conducting product safety reviews, and performing comparative value analysis. Its automated solutions enable clinicians to efficiently track patient interactions with caregivers and biomedical technologies. Additionally, Genesis offers an automated supply management system that allows healthcare professionals to monitor supplies and devices throughout the internal distribution process. The company has established strategic partnerships with organizations such as HFMA and the Healthcare Costing for Value Institute. Founded in 2016, Genesis Automation USA, Inc. is headquartered in Hermosa Beach, California, with an additional office in St. Petersburg, Florida, and operates as a subsidiary of Genesis Automation UK Ltd.

Genesis Automation is a single source, full-service automated system solutions provider. It designs and builds high-precision assembly, test, and special process equipment for a wide range of industries. Genesis Automation was founded in 1999 and is based in Cork, Ireland.

Lumeon Ltd. is a digital health company specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and headquartered in London, the company offers a cloud-based platform known as the Care Pathway Manager, which provides a comprehensive, real-time view of the patient journey from referral to outcome. Lumeon's services encompass business analysis, project management, data migration, training, and ongoing support. By focusing on the entire care pathway, Lumeon aids healthcare providers in optimizing clinical and administrative workflows, automating tasks, and achieving measurable healthcare outcomes. The company serves a diverse range of clients, including some of Europe's leading healthcare organizations. Lumeon was previously known as Qinec Ltd. before rebranding in July 2016.

Mauna Kea Technologies is a global medical device company headquartered in Paris, France, that specializes in the development and marketing of technologies aimed at improving the diagnosis and treatment of cancers and other diseases. Founded in 2000, the company’s flagship product, Cellvizio, is a confocal laser endomicroscopy platform that enables real-time in vivo microscopic visualization of tissues at the cellular level. This innovative technology provides physicians and researchers with critical imaging capabilities, enhancing diagnostic accuracy and treatment effectiveness. Cellvizio has received regulatory clearance and approval for various applications in the United States and over 40 countries worldwide, underscoring its significance in the medical field.

Impeto Medical is a privately owned medical device company formed in June 2005 with its corporate headquarters in Paris, France. Impeto Medical manufactures and markets devices designed for non-invasive assessment of eccrine sweat gland activity.

Neuravi Limited is a medical device company based in Galway, Ireland, focused on developing clot retrieval devices to restore blood flow in patients who have experienced ischemic strokes caused by arterial blockages in the brain. The company offers the EmboTrap revascularization devices, which are designed for the treatment of acute ischemic strokes and are available in several European countries, including Belgium, Denmark, France, Germany, and Spain. Founded in 2009, Neuravi operates in the emerging neurointerventional device market and collaborates with researchers and clinicians to advance treatment solutions for this serious condition. As of April 2017, Neuravi is a subsidiary of DePuy Ireland Unlimited Company.

i-Optics is a medical device company based in The Hague, Netherlands, specializing in advanced corneal diagnostic solutions. Founded in 2006, it focuses on empowering cataract surgeons by providing a comprehensive suite of examinations necessary for toric, multifocal, and extended depth of focus intraocular lens implantation. Its technology includes corneal topography, posterior corneal analysis, mesopic and photopic pupillometry, and full-color photography, all designed to enhance the understanding of corneal properties. By employing innovative techniques such as ray tracing and a unique LED positioning system, i-Optics aims to improve surgical outcomes and increase the volume of premium patient care.

Genesis Automation USA, Inc. specializes in supplies management, analytics, and traceability solutions tailored for the healthcare sector. The company focuses on enhancing clinical and patient outcome data management, facilitating patient-level cost tracking, conducting product safety reviews, and performing comparative value analysis. Its automated solutions enable clinicians to efficiently track patient interactions with caregivers and biomedical technologies. Additionally, Genesis offers an automated supply management system that allows healthcare professionals to monitor supplies and devices throughout the internal distribution process. The company has established strategic partnerships with organizations such as HFMA and the Healthcare Costing for Value Institute. Founded in 2016, Genesis Automation USA, Inc. is headquartered in Hermosa Beach, California, with an additional office in St. Petersburg, Florida, and operates as a subsidiary of Genesis Automation UK Ltd.

SpineGuard SA is a medical device company headquartered in Vincennes, France, focused on enhancing the safety of spinal surgeries worldwide. Established in 2009, the company designs, develops, and markets innovative products aimed at improving pedicle screw placement during surgical procedures. Its key offerings include the PediGuard Straight probe, PediGuard Curved probe, PediGuard Cannulated probe, and the PediGuard Threaded Device, all designed to facilitate accurate screw placement while minimizing radiation exposure. Additionally, SpineGuard provides the DSG Connect app for real-time signal visualization during pedicle drilling, as well as the DSG smart screw for single-step screw placement. The company's primary goal is to establish PediGuard as the standard of care for safer spinal procedures, ultimately benefiting patients, surgeons, and healthcare providers.

Mainstay Medical Holdings plc is a medical device company based in Dublin, Ireland, with operations in the United States and Australia. Founded in 2008, the company is dedicated to developing and commercializing innovative therapies for chronic low back pain, a condition affecting a significant portion of the population. Its flagship product, ReActiv8, is an implantable neurostimulation system that aims to restore control to the muscles stabilizing the lumbar spine. Mainstay Medical collaborates with scientists and clinical experts to address the unmet needs of patients suffering from debilitating back pain, combining expertise in engineering and clinical development to deliver effective solutions in this challenging medical area.

i-Optics B.V. is a medical device company based in The Hague, Netherlands, specializing in the development and distribution of optical devices for eye diagnosis. Founded in 2003, the company offers innovative solutions such as Cassini, a corneal shape analyzer that utilizes color LED technology to measure the true axis and magnitude of corneal astigmatism, which is crucial for premium intraocular lens (IOL) planning. Additionally, i-Optics provides EasyScan, a retinal imaging system that employs scanning laser ophthalmoscopy (SLO) technology to diagnose various retinal diseases, including diabetic retinopathy, age-related macular degeneration, and glaucoma, without the need for pupil dilation. Through its advanced, user-friendly products, i-Optics aims to enhance the quality of eye care for healthcare providers and their patients worldwide.

EOS imaging is a medical company revolutionizing the treatment continuum for the most common osteoarticular conditions (hip, knee and spine) and associated orthopedic surgeries. Its EOS® 2D/3D imaging system is specifically adapted to the needs of orthopedic surgeons and radiologists. This personalized imaging tool gives a precise 3D image of the patient's skeleton in the upright position that can be used to inform all aspects of care. The Company has obtained authorization to market the system in 48 countries. The Company is based in Paris, with a subsidiary in the United States in Cambridge, Massachusetts, as well as offices in Montreal (Canada) and Germany.

Mendor is a Finnish company, committed to the design, development and marketing of advanced diabetes management products. Mendor has launched a revolutionary, discreet, easy to use, portable all-in-one blood glucose meter and web-based software application for the daily management of diabetes. Mendor has designed its products together with users and diabetes experts to address the needs of people with diabetes requiring regular blood glucose monitoring.

BONESUPPORT is a medical technology company dedicated to the development of injectable osteoconductive biomaterials for the treatment of fragility fractures caused by osteoporosis, and bone voids or gaps caused by trauma, disease or related to surgical procedures. The company's mission is to restore health to enhance the quality of life for patients with bone disorders. BONESUPPORT was founded on 2000 and is headquartered in Lund, Sweden.